Tyr Pharma has a pivotal year ahead with key readouts for Efzofitimod, potentially opening a huge market. Find out why ATYR ...

Crown Princess Mette-Marit of Norway is on sick leave due to medicinal side effects associated with her chronic lung disease, ...

A panel for the Centers for Disease Control and Prevention voted to lower the recommended age for older adults to get their ...

New funding from Biocurate will support a Monash University project that's developing a novel disease-modifying treatment for ...

Carvedilol and metoprolol are both beta-blocker medications used to treat cardiovascular conditions. Find out which is right ...

A University of Alberta pharmacology researcher has discovered that a new experimental anti-obesity drug improves diastolic ...

AstraZeneca has rolled out a fresh TV spot for its blockbuster-to-be Breztri, hitting the me | AstraZeneca has rolled out a ...

Exploring Chronic obstructive pulmonary disease (COPD), this infographic highlights the global incidence, current management ...

The FDA has cleared the start of clinical trial testing of KT-621, an experimental oral medication for COPD and other ...

The global Chronic Obstructive Pulmonary Disease (COPD) treatment market is projected to experience steady growth over the ...

Tectonic Therapeutic's lead candidate TX45 showed positive phase 1 results for Group 2 Pulmonary Hypertension. Read why I ...

((SL Advertiser)) New treatment option for those with chronic obstructive pulmonary disease or COPD. To learn more, go to ...